BRIEF—Reig Jofre launches remifentanil in Korea

Spain’s Reig Jofre has begun marketing remifentanil, an in-hospital anesthetic, in the Korean market. The firm has now completed registration in Korea, following approval of a designated production plant by the Korean Food and Drug Administration (KFDA).

Reig Jofre manufactures around a third of the world’s supply of injectable vials of remifentanil at its Barcelona-based plant.

The ultra-short-acting anesthetic has now been launched in more than 30 countries.